Objectives: Cyclins play an important role in the regulation of cell progre
ssion through the cell cycle. Over-expression of the cyclins has been shown
in many different tumour types. Pituitary adenomas are a common form of en
docrine neoplasia in the human, but have been little studied in terms of th
e expression of the principal cyclins regulating checkpoint exit, cyclin D1
and cyclin E.
Methods: We therefore investigated the expression of cyclin D1 and cyclin E
in a range of benign and metastatic pituitary tumours. We studied a total
of 95 pituitaries. including normal pituitary (n = 20), Gushing's disease (
n = 19), somatotroph tumours (n = 19), non-functioning adenomas (n = 18), p
rolactinomas (n = 7), aggressive tumours (n = 9) and pituitary carcinoma (n
= 3). All tumours and normal tissue were immunostained for cyclin D1 and c
yclin E using a standard technique, and were then subjected to blinded anal
ysis by a single observer and the extent of staining quantified on the basi
s of 500 cell counts per tissue. The distribution of positive staining betw
een different tissues was analysed by non-parametric test procedures.
Results: There was no cytoplasmic staining for cyclin D1 in any tissue. Nuc
lear staining was generally sparse, but was statistically more frequent in
non-functioning and aggressive tumours compared with other tumour types or
normal pituitary. Cyclin E was also sparsely expressed, but was specificall
y increased in corticotroph tumours from patients with Gushing's disease.
Conclusions: We report cyclin D1 over-expression in aggressive and non-func
tioning pituitary tumours, and that cyclin E expression is more frequently
seen in Gushing's disease. The high level of cyclin E expression in Gushing
's disease may relate to the low level of p27 protein expression previously
reported in corticotroph tumours.